Asset Dedication’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
Bought
Maintained
Sold
Other funds holding FTXH
Asset Dedication's FTXH Position: Q3 2026 in Review
Asset Dedication held its First Trust Nasdaq Pharmaceuticals ETF (FTXH) position steady in Q3 2026 at 593 shares worth $24.6K. The position accounts for ﹤0.01% of the portfolio, ranked #616.
Asset Dedication first reported a position in FTXH in Q2 2020 and has held it in 26 quarters since. 57 funds tracked by Wall St. Rank hold FTXH as of Q3 2026.
- Asset Dedication held 593 shares of First Trust Nasdaq Pharmaceuticals ETF worth $24.6K as of Q3 2026.
- Asset Dedication left its First Trust Nasdaq Pharmaceuticals ETF share count unchanged in Q3 2026.
- First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of Asset Dedication's portfolio in Q3 2026, its #616 holding.
- Asset Dedication first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q2 2020 and has held it in 26 quarters since.
- 57 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q3 2026.
Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.